BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

675 related articles for article (PubMed ID: 19800175)

  • 1. Interaction in COPD experiment (ICE): a hazardous combination of cigarette smoking and bronchodilation in chronic obstructive pulmonary disease.
    van Dijk WD; Heijdra Y; Scheepers PT; Lenders JW; van Weel C; Schermer TR
    Med Hypotheses; 2010 Feb; 74(2):277-80. PubMed ID: 19800175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cigarette smoke retention and bronchodilation in patients with COPD. A controlled randomized trial.
    van Dijk WD; Heijdra Y; Lenders JW; Klerx W; Akkermans R; van der Pouw A; van Weel C; Scheepers PT; Schermer TR
    Respir Med; 2013 Jan; 107(1):112-9. PubMed ID: 23069326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A method to study the effect of bronchodilators on smoke retention in COPD patients: study protocol for a randomized controlled trial.
    van Dijk WD; Scheepers PT; Cremers R; Lenders JW; Klerx W; van Weel C; Schermer TR; Heijdra Y
    Trials; 2011 Feb; 12():37. PubMed ID: 21310040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic obstructive pulmonary disease: a novel risk factor for cardiovascular disease.
    Sin DD; Man SF
    Can J Physiol Pharmacol; 2005 Jan; 83(1):8-13. PubMed ID: 15759045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-acting bronchodilator therapy for the treatment of chronic obstructive pulmonary disease.
    Chen AM; Bollmeier SG; Finnegan PM
    Ann Pharmacother; 2008 Dec; 42(12):1832-42. PubMed ID: 18957624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bronchodilation and smoking interaction in COPD: a cohort pilot study to assess cardiovascular risk.
    van Dijk WD; Lenders JW; Holtman J; Grootens J; Akkermans R; Heijdra Y; van Weel C; Schermer TR
    Respiration; 2012; 83(2):125-32. PubMed ID: 21555867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevalence and difficulties in chronic obstructive pulmonary disease diagnosis in patients suffering from severe peripheral arterial disease].
    Sleszycka J; Woźniak K; Banaszek M; Wiechno W; Domagała-Kulawik J
    Pol Merkur Lekarski; 2009 Aug; 27(158):92-6. PubMed ID: 19856871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The occurrence of chronic obstructive pulmonary disease (COPD) in cigarette smoking families.
    Kałucka S
    Przegl Lek; 2006; 63(10):848-57. PubMed ID: 17288170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
    Baker WL; Baker EL; Coleman CI
    Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of outpatients with COPD in daily practice: The E4 Spanish project.
    Viejo-Bañuelos JL; Pueyo-Bastida A; Fueyo-Rodríguez A
    Respir Med; 2006 Dec; 100(12):2137-43. PubMed ID: 16831541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
    Sobieraj DM; White CM; Coleman CI
    Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Better understanding the influence of cigarette smoking and indoor air pollution on chronic obstructive pulmonary disease: a case-control study in Mainland China.
    Xu F; Yin X; Shen H; Xu Y; Ware RS; Owen N
    Respirology; 2007 Nov; 12(6):891-7. PubMed ID: 17986120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consequences of passive smoking in home environment.
    Kałucka S
    Przegl Lek; 2007; 64(10):632-41. PubMed ID: 18409274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular mortality and morbidity in chronic obstructive pulmonary disease: the impact of bronchodilator treatment.
    Wood-Baker R; Cochrane B; Naughton MT
    Intern Med J; 2010 Feb; 40(2):94-101. PubMed ID: 19849745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in chronic obstructive pulmonary disease.
    Barnes PJ
    Trans Med Soc Lond; 2002-2003; 119():41-51. PubMed ID: 17184031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tiotropium (Spiriva) - a long-acting inhaled anticholinergic for the treatment of chronic obstructive pulmonary disease (COPD)].
    Beeh KM; Welte T; Buhl R
    Pneumologie; 2003 Sep; 57(9):519-25. PubMed ID: 13680472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical course of chronic obstructive pulmonary disease: review of therapeutic interventions.
    Anzueto A
    Am J Med; 2006 Oct; 119(10 Suppl 1):46-53. PubMed ID: 16996899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chronic obstructive pulmonary disease and cardiovascular system].
    Gürgün A; Gürgün C
    Tuberk Toraks; 2008; 56(4):464-71. PubMed ID: 19123087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronic obstructive pulmonary disease (COPD) and its future].
    Tatlicioğlu T
    Tuberk Toraks; 2007; 55(3):303-18. PubMed ID: 17978931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of inhaled corticosteroids on exhaled nitric oxide in stable chronic obstructive pulmonary disease.
    Zietkowski Z; Kucharewicz I; Bodzenta-Lukaszyk A
    Respir Med; 2005 Jul; 99(7):816-24. PubMed ID: 15939243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.